Cytokeratin 19 Rekombinanter Antikörper
Cytokeratin 19 Rekombinant Antikörper für WB, IHC, IF/ICC, IF-P, FC (Intra), Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, IF-P, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250894B1
Kat-Nr. : 86250-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86250-1-PBS bindet in WB, IHC, IF/ICC, IF-P, FC (Intra), Indirect ELISA Cytokeratin 19 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Peptid |
| Vollständiger Name | keratin 19 |
| Berechnetes Molekulargewicht | 44 kDa |
| Beobachtetes Molekulargewicht | 44 kDa |
| GenBank-Zugangsnummer | BC002539 |
| Gene symbol | Cytokeratin 19 |
| Gene ID (NCBI) | 3880 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Cytokeratin 19 (CK19 or KRT19) is a type I (acidic) cytokeratin. It is an intermediate filament protein providing structural rigidity and multipurpose scaffolds in epithelial cells. CK19 is often overexpressed in various cancers (e.g., hepatocellular carcinoma [HCC], pancreatic adenocarcinoma, lung cancer) and serves as a biomarker for hepatic progenitor cells (HPCs) associated with poor prognosis in HCC patients . Additionally, CK19 expression is common in pancreatic and gastrointestinal adenocarcinomasand has been studied as a potential diagnostic and prognostic marker for pancreatic neuroendocrine tumors (PNETs), where positive CK19 expression correlates with poor prognosis. Serum CK19 fragments (e.g., CYFRA 21-1, CK19-2G2) have been investigated as tumor markers for lung and breast cancer, with preoperative levels associated with metastasis and survival.



























